ATE111082T1 - 3-sulfonylamino-2-(1h)-chinolinone und deren 7- azaderivate als anregende aminosäuren antagonisten. - Google Patents
3-sulfonylamino-2-(1h)-chinolinone und deren 7- azaderivate als anregende aminosäuren antagonisten.Info
- Publication number
- ATE111082T1 ATE111082T1 AT92403014T AT92403014T ATE111082T1 AT E111082 T1 ATE111082 T1 AT E111082T1 AT 92403014 T AT92403014 T AT 92403014T AT 92403014 T AT92403014 T AT 92403014T AT E111082 T1 ATE111082 T1 AT E111082T1
- Authority
- AT
- Austria
- Prior art keywords
- branched
- linear
- trihalomethyl
- unsubstituted
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9113977A FR2683818B1 (fr) | 1991-11-14 | 1991-11-14 | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE111082T1 true ATE111082T1 (de) | 1994-09-15 |
Family
ID=9418879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92403014T ATE111082T1 (de) | 1991-11-14 | 1992-11-09 | 3-sulfonylamino-2-(1h)-chinolinone und deren 7- azaderivate als anregende aminosäuren antagonisten. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0542609B1 (de) |
| JP (1) | JPH06102650B2 (de) |
| AT (1) | ATE111082T1 (de) |
| AU (1) | AU651255B2 (de) |
| CA (1) | CA2082856A1 (de) |
| DE (1) | DE69200394T2 (de) |
| DK (1) | DK0542609T3 (de) |
| ES (1) | ES2064156T3 (de) |
| FR (1) | FR2683818B1 (de) |
| NZ (1) | NZ245127A (de) |
| ZA (1) | ZA928727B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2709489B1 (fr) * | 1993-08-31 | 1995-10-20 | Adir | Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| FR2750988B1 (fr) * | 1996-07-11 | 1998-09-18 | Adir | Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1158985B1 (de) | 1999-01-13 | 2011-12-28 | Bayer HealthCare LLC | GAMMA CARBOXYARYLSUBSTITUIERTE DIPHENYLHARNSTOFFVERBINDUNGEN ALS p38 KINASEHEMMER |
| CA2549558C (en) | 1999-01-13 | 2010-08-31 | Bayer Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US20020065296A1 (en) | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| JP2003508397A (ja) | 1999-08-27 | 2003-03-04 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アンドロゲンレセプターモジュレーターとしての８−置換−６−トリフルオロメチル−９−ピリド［３，２−ｇ］キノリン化合物 |
| US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| KR20020038741A (ko) | 1999-08-27 | 2002-05-23 | 윌리암 엘. 레스페스 | 안드로겐 수용체 조절 화합물 및 방법 |
| AU7586600A (en) | 1999-09-14 | 2001-04-17 | Ligand Pharmaceuticals Incorporated | Rxr modulators with improved pharmacologic profile |
| FR2805262A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2805260A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2805261A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TWI298068B (en) * | 2000-06-21 | 2008-06-21 | Dainippon Sumitomo Pharma Co | Pharmaceutical composition for schizophrenia |
| EP1636585B2 (de) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl-harnstoffe mit kinasehemmender wirkung |
| MXPA06001751A (es) | 2003-08-22 | 2006-05-12 | Ligand Pharm Inc | Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno. |
| JP2009513707A (ja) | 2005-10-31 | 2009-04-02 | バイエル ヘルスケア リミティド ライアビリティ カンパニー | ジアリールウレア及び併用剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3066145A (en) * | 1962-02-07 | 1962-11-27 | American Home Prod | 3-amino-6-chloro-4-phenyl-2(1h)-quinolone |
| EP0386839B1 (de) * | 1989-03-08 | 1997-01-15 | Merck Sharp & Dohme Ltd. | Tetrahydroquinolin-Derivate, verwendbar bei neurodegenerativen Krankheiten |
| GB9004288D0 (en) * | 1990-02-26 | 1990-04-18 | Almirall Lab | New 4(1h)quinoline derivatives |
-
1991
- 1991-11-14 FR FR9113977A patent/FR2683818B1/fr not_active Expired - Fee Related
-
1992
- 1992-11-09 ES ES92403014T patent/ES2064156T3/es not_active Expired - Lifetime
- 1992-11-09 DK DK92403014.1T patent/DK0542609T3/da active
- 1992-11-09 DE DE69200394T patent/DE69200394T2/de not_active Expired - Fee Related
- 1992-11-09 AT AT92403014T patent/ATE111082T1/de active
- 1992-11-09 EP EP92403014A patent/EP0542609B1/de not_active Expired - Lifetime
- 1992-11-12 ZA ZA928727A patent/ZA928727B/xx unknown
- 1992-11-13 NZ NZ24512792A patent/NZ245127A/en unknown
- 1992-11-13 AU AU28351/92A patent/AU651255B2/en not_active Ceased
- 1992-11-13 CA CA002082856A patent/CA2082856A1/fr not_active Abandoned
- 1992-11-16 JP JP4305550A patent/JPH06102650B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU651255B2 (en) | 1994-07-14 |
| FR2683818B1 (fr) | 1993-12-31 |
| DK0542609T3 (da) | 1995-03-20 |
| DE69200394T2 (de) | 1995-04-27 |
| EP0542609A1 (de) | 1993-05-19 |
| JPH05221997A (ja) | 1993-08-31 |
| DE69200394D1 (de) | 1994-10-13 |
| ES2064156T3 (es) | 1995-01-16 |
| FR2683818A1 (fr) | 1993-05-21 |
| NZ245127A (en) | 1994-07-26 |
| EP0542609B1 (de) | 1994-09-07 |
| ZA928727B (en) | 1993-05-10 |
| CA2082856A1 (fr) | 1993-05-15 |
| AU2835192A (en) | 1993-05-20 |
| JPH06102650B2 (ja) | 1994-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE111082T1 (de) | 3-sulfonylamino-2-(1h)-chinolinone und deren 7- azaderivate als anregende aminosäuren antagonisten. | |
| NO923528D0 (no) | Benzyliden-karbamoyl-pyrrolidonanaloger | |
| NL300034I2 (nl) | Gesubstitueerde thiahzolidinedionderivaten. | |
| NO950009D0 (no) | Heterocykliske forbindelser som farmasöytika | |
| DE3888756D1 (de) | Carbamoylpyrrolidonderivate, ihre Verwendung und Herstellung. | |
| MX9204029A (es) | Procedimiento de preparacion de un derivado de la bacatina iii y de la 10-desacetil bacatina iii | |
| FR2398718A1 (fr) | Nouvelles amines primaires utiles a la preparation de derives d'aminoalkyl benzenes | |
| BG97221A (bg) | Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства | |
| DE3874633D1 (de) | Ferroelektrische fluessigkristallzusammensetzung. | |
| ATE146776T1 (de) | Phenethylalkohol derivate und diese enthaltende aufzeichnungsmaterialien | |
| ATE69605T1 (de) | Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide. | |
| DE69409734D1 (de) | Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| NO930068D0 (no) | Nye kjemiske forbindelser | |
| ATE128131T1 (de) | Substituierte pyridinsulfonamide oder deren salze, verfahren zur herstellung und diese enthaltende herbizide. | |
| EP0349274A3 (en) | Photographic dot enhancing compositions and methods for their use | |
| IL106564A (en) | Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
| SE8100122L (sv) | Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa | |
| KR940011218A (ko) | 승화형 열전사 기록용 색소 | |
| SE8200320L (sv) | Nya derivat av spiro-1 isobensofuraner och spiro-1 isobensotiofener, derasframstellningssett och terapeutiska anvendning | |
| KR940011219A (ko) | 승화형 열전사 기록용 색소 | |
| ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. |